Colgate Palmolive (India) Limited (COLPAL) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Colgate Palmolive (India) Limited ₹946, price ₹1,735, upside -45.5%, quality 80 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range ₹1,259 – ₹3,683 · fair‑value band ₹695.65 – ₹1,186 · the ₹1,735 price screens above the ₹945.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Colgate Palmolive (India) in your weekly email
Every Wednesday you see whether Colgate Palmolive (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products.
Show more
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India.
Stock analysis
Colgate Palmolive (India) Limited (COLPAL) currently trades at ₹1,735, while our model-based Fair Value estimate is ₹945.90, 45.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹1,031 per share, and 0 of the 26 models we run sit above the ₹1,735 price.
Bear case: the Economic Profit group reads lowest at ₹222.08, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹695.65 (bear) to ₹1,186 (bull), the price of ₹1,735 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 80/100 (high quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Colgate Palmolive (India) Limited reported revenue of ₹60.4B in FY2026 versus ₹50.7B in FY2022, a compound +4.5%/yr. Reported net income was ₹13.3B in FY2026, compounding +5.3%/yr from FY2022.
Key figures
Market cap ₹547B (≈ $5.7B) · P/E ratio 35.6 · P/S ratio 7.82 · EPS (TTM) ₹48.72 · Dividend yield 2.9% · Net margin 22.0% · Return on equity 81.6% · Return on assets (EBIT) 52.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 62 out of 100 (medium confidence).
What moves the price
The share trades about 24% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −15% fair-value upside, at −45%, COLPAL screens richer than that median.
Fair Value models
Bear ₹695.65Fair Value ₹945.90Bull ₹1,186
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.78/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
Start year 2021 (pandemic). Over 10 years: +4.6% a year
Revenue growth 28 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+8.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.1%
Dividend (yield on the price)2.9%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.1% vs 8.7%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.28% → 29%
Start year 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+6.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +12.4% a year for the price and +2.7% for the forecasts.
Compare Colgate Palmolive (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 235 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score80 · Top 25%
Fair Value upside−54.6% · Bottom 25%
Profitability
Return on equity (TTM)81.6% · Top 25%
Return on assets33.6% · Top 25%
Net margin (TTM)22.0% · Top 25%
Operating margin (TTM)30.0% · Top 25%
Growth and dividend
Revenue growth9.1% · Above median
Dividend yield (TTM)2.9% · Above median
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/E (TTM)35.6× · Priciest 25%
P/B34.54× · Priciest 25%
P/S (TTM)9.07× · Priciest 25%
P/FCF30.6× · Priciest 25%
EV/EBITDA28.7× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)46· sector 16
PAST (return on equity)100· sector 30
HEALTH (low debt)100· sector 98
DIVIDEND (yield)59· sector 54
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Colgate Palmolive (India) Limited (COLPAL) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of ₹945.90 versus a price of ₹1,735, about −45% upside (overvalued).
What is the fair value of COLPAL?
Our model-based fair value for Colgate Palmolive (India) Limited is ₹945.90 (as of Sep 23, 2026), built from audited fundamentals. The current price: ₹1,735.
What is the quality score of COLPAL?
Colgate Palmolive (India) Limited has a Quality Score of 80/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Colgate Palmolive (India) Limited (COLPAL)?
Our model-based price target is the fair value of ₹945.90 (as of Sep 23, 2026) from 26 valuation models. Cautious scenario ₹695.65, optimistic scenario ₹1,186. It is a calculation from audited fundamentals, not an analyst target.
What is the Colgate Palmolive (India) Limited stock forecast for 2026?
Our models put fair value at ₹945.90, about −45% upside versus a price of ₹1,735 (overvalued). Cautious scenario ₹695.65, optimistic scenario ₹1,186. The calculation is refreshed regularly with new filings.
What is the revenue of Colgate Palmolive (India) Limited (COLPAL)?
Colgate Palmolive (India) Limited reported trailing-twelve-month revenue of about ₹60.4B (latest available figure, as of Sep 23, 2026).
Does Colgate Palmolive (India) Limited pay a dividend?
Colgate Palmolive (India) Limited currently shows a dividend yield of about 2.94% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Colgate Palmolive (India) Limited (COLPAL)?
For today's price to be fair in a discounted-cash-flow model, Colgate Palmolive (India) Limited would have to grow free cash flow by +17.1 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.5 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of COLPAL use?
Our models discount Colgate Palmolive (India) Limited at 10.9 %: a base by market capitalisation (mid), damped by beta 0.51, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Colgate Palmolive (India) Limited that is +17.1 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Colgate Palmolive (India) Limited (COLPAL) delivered so far?
Over the past 5 years revenue at Colgate Palmolive (India) Limited grew +4.5 % a year. The price currently implies +17.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Colgate Palmolive (India) Limited (COLPAL) growing?
The median revenue growth in the sector is +2.8 % a year. That is the yardstick for the growth priced into Colgate Palmolive (India) Limited (+17.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Colgate Palmolive (India) Limited (COLPAL)?
The free-cash-flow yield on the price is 3.79 %: that much free cash flow Colgate Palmolive (India) Limited produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Colgate Palmolive (India) Limited (COLPAL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Colgate Palmolive (India) Limited it is ₹945.90 per share (as of Sep 23, 2026), against a price of ₹1,735. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Colgate Palmolive (India) Limited stock overvalued or undervalued in 2026?
As of Sep 23, 2026, COLPAL trades above its calculated fair value: price ₹1,735, fair value ₹945.90, a gap of about −45% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of COLPAL?
No. The price is what the market pays today (₹1,735); the fair value is what the company's own numbers justify (₹945.90). For Colgate Palmolive (India) Limited the two are ₹789.10 per share apart. That gap is exactly why we show both numbers side by side.
How much is Colgate Palmolive (India) Limited worth?
The market values Colgate Palmolive (India) Limited at about ₹547B (market capitalisation, as of Sep 23, 2026). Per share that is ₹1,735; our models calculate a fair value of ₹945.90 per share.
What do the bullish and bearish scenarios say about COLPAL?
Our models span a range for Colgate Palmolive (India) Limited: cautious scenario ₹695.65, base ₹945.90, optimistic ₹1,186 per share (as of Sep 23, 2026, price ₹1,735). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of COLPAL?
Colgate Palmolive (India) Limited trades at a price-to-earnings ratio of 35.6 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹945.90 is built from several models across several years. Other multiples: P/B 34.5, P/S 9.1, EV/EBITDA 28.7.
How solid is the balance sheet of Colgate Palmolive (India) Limited (COLPAL)?
Balance-sheet figures for Colgate Palmolive (India) Limited (as of Sep 23, 2026): return on equity 81.6%. They feed the Quality Score of 80/100, which measures business quality independently of the share price.
How far is COLPAL from its 52-week high?
Colgate Palmolive (India) Limited trades at ₹1,735, about 24% below its 52-week high of ₹2,269 and at the low of ₹1,735 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹945.90 is for.
Which stocks are comparable to Colgate Palmolive (India) Limited?
From the same area (Consumer Defensive) we also value Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Colgate Palmolive (India) Limited stock attractive at the current price?
The data as of Sep 23, 2026: price ₹1,735, calculated fair value ₹945.90 (−45%), Quality Score 80/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of COLPAL calculated?
We run Colgate Palmolive (India) Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹945.90, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Colgate Palmolive (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Colgate Palmolive (India) Limited (COLPAL)?
The closing price on Oct 1, 2026 was ₹1,735. Our model-based fair value is ₹945.90, about −45% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Colgate Palmolive (India) Limited right now?
A high-quality business (quality 80/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (₹1,186). The favourable scenario is already priced in.
Where does the earnings growth of Colgate Palmolive (India) Limited (COLPAL) come from?
Earnings per share at Colgate Palmolive (India) Limited grew +10.1 % a year from 2015 to 2026. Broken into its drivers: revenue per share +4.6 %, EBIT margin +4.3 %, tax rate +0.7 %, residual (interest, one-offs) +0.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Colgate Palmolive (India) Limited
How large is the market capitalisation of Colgate Palmolive (India) Limited (COLPAL)?
The market capitalisation of Colgate Palmolive (India) Limited is ₹547B (≈ $5.7B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Colgate Palmolive (India) Limited (COLPAL)?
The price-to-sales ratio of Colgate Palmolive (India) Limited is 7.82 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Colgate Palmolive (India) Limited (COLPAL)?
Earnings per share at Colgate Palmolive (India) Limited are ₹48.72 (price ÷ EPS = P/E 35.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Colgate Palmolive (India) Limited (COLPAL)?
The dividend yield of Colgate Palmolive (India) Limited is 2.9% (payout 105%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Colgate Palmolive (India) Limited (COLPAL)?
The net margin of Colgate Palmolive (India) Limited is 22.0% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Colgate Palmolive (India) Limited (COLPAL)?
The return on equity (ROE) of Colgate Palmolive (India) Limited is 81.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Colgate Palmolive (India) Limited (COLPAL)?
On an EBIT basis the return on assets of Colgate Palmolive (India) Limited is 52.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Colgate Palmolive (India) Limited (COLPAL)?
The operating margin of Colgate Palmolive (India) Limited is 30.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Colgate Palmolive (India) Limited (COLPAL)?
Revenue at Colgate Palmolive (India) Limited is growing +9.1% versus a year earlier (3y avg +5.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Colgate Palmolive (India) Limited (COLPAL)?
Earnings per share at Colgate Palmolive (India) Limited are growing −0.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Colgate Palmolive (India) Limited (COLPAL) hold?
Colgate Palmolive (India) Limited holds more cash than debt, ₹14.2B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
